Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024
Compare Balance Sheet Results of Norris Medicines
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.93
17.00
-7.07
-41.59%
Share Warrants & Outstandings
Total Reserve
-24.79
8.47
-33.26
-392.68%
Shareholder's Funds
-14.87
25.47
-40.34
-158.38%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
18.53
0.00
18.53
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
18.53
0.00
18.53
0.00%
Deferred Tax Assets / Liabilities
-0.90
-0.08
-0.82
-1,025.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
17.62
-0.08
17.70
22,125.00%
Current Liabilities
Trade Payables
2.57
0.06
2.51
4,183.33%
Other Current Liabilities
1.79
0.01
1.78
17,800.00%
Short Term Borrowings
3.05
1.07
1.98
185.05%
Short Term Provisions
2.74
0.00
2.74
0.00%
Total Current Liabilities
10.15
1.14
9.01
790.35%
Total Liabilities
12.91
26.53
-13.62
-51.34%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.76
0.84
26.92
3,204.76%
Less: Accumulated Depreciation
22.49
0.71
21.78
3,067.61%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.27
0.13
5.14
3,953.85%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.01
8.30
-8.29
-99.88%
Long Term Loans & Advances
1.29
0.00
1.29
0.00%
Other Non Current Assets
0.00
2.08
-2.08
-100.00%
Total Non-Current Assets
6.57
10.51
-3.94
-37.49%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.13
5.12
-0.99
-19.34%
Sundry Debtors
1.41
5.78
-4.37
-75.61%
Cash and Bank
0.04
4.49
-4.45
-99.11%
Other Current Assets
0.74
0.45
0.29
64.44%
Short Term Loans and Advances
0.02
0.18
-0.16
-88.89%
Total Current Assets
6.34
16.02
-9.68
-60.42%
Net Current Assets (Including Current Investments)
-3.81
14.88
-18.69
-125.60%
Total Current Assets Excluding Current Investments
6.34
16.02
-9.68
-60.42%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
12.91
26.53
-13.62
-51.34%
Contingent Liabilities
1.33
0.00
1.33
0.00%
Total Debt
21.58
1.07
20.51
1,916.82%
Book Value per share (adjusted)
-14.98
14.98
-29.96
-200.00%
Annual - Borrowings
Borrowings 21.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Annual - Investments
Investments 0.01 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 6.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024






